SCHEMBL30950504

SCHEMBL30950504

C#CC(=O)Nc1ccccc1-c1nc2c(-c3ccc(CNC(=O)c4nc(C(C)(C)C)no4)c(F)c3)ccnc2[nH]1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 20/20 0.56
▸ LCK P06239 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27453590 1.00 BTK (0.56) BTKLCK
SCHEMBL27453588 0.93 BTK (0.56) BTKLCK
SCHEMBL30950520 0.93 BTK (0.56) BTKLCK
SCHEMBL30950573 0.92 BTK (0.59) BTKLCK
SCHEMBL27459684 0.92 BTK (0.59) BTKLCK
SCHEMBL17645657 0.90 BTK (0.57) BTKLCK
SCHEMBL27460048 0.90 BTK (0.57) BTKLCK
SCHEMBL30950578 0.90 BTK (0.57) BTKLCK
SCHEMBL30950597 0.89 BTK (0.56) BTKLCK
SCHEMBL27453497 0.89 BTK (0.56) BTKLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129395-A1 BTK INHIBITORS GWYNANT THERAPEUTICS, INC. (US) 2024-06-20 — — WO disclosed
Send feedback